MedTrace Logo

Efficacy of Dietary Supplement in Subjects With Acid Reflux and/or Abdominal Bloating/Distention and GI Symptoms

NCT06808867 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 85

Last updated 2025-02-05

No results posted yet for this study

Summary

This study was a prospective randomized clinical study. There was interventional treatment for a total of 8 weeks including a 2-week washout period. The subjects attended four appointments in the clinic throughout the duration of the study.

Study Primary Objective:

• To assess improvement in bloating symptoms

Study Secondary Objectives:

* To assess safety and tolerability of the formulation
* To compare the time taken for perceptual improvement in bloating/distention
* Enzyme blood assays
* To assess quality of life indices

Conditions

  • Healthy

Interventions

DIETARY_SUPPLEMENT

Placebo

Eligible subjects will receive Placebo to take daily for six weeks

DIETARY_SUPPLEMENT

Dietary Supplement with Active Ingredient Blend

Eligible subjects will receive Active supplement to take daily for six weeks

Sponsors & Collaborators

  • Olly, PBC

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-02-25
Primary Completion
2024-04-15
Completion
2024-04-15

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06808867 on ClinicalTrials.gov